BRCA1 and female reproductive organ cancer: The role of an FH of EOC as a predictor of EOC risk is already demonstrated, especially among BRCA1 mutation carriers (Texeira et al., 2018); this is highly relevant considering that EOC is the third most common gynecologic cancer and has the worst prognosis and the highest mortality rate (Bray et al., 2018; Coburn et al., 2017; Momenimovahed et al., 2019).